Notices. Notice of five AHRQ subcommittee meetings
341 words·~2 min read·
/register/2024/12/18/2024-29969·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
BILLING CODE 6210-01-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Agency for Healthcare Research and Quality Notice of Meetings AGENCY: Agency for Healthcare Research and Quality (AHRQ), Department of Health and Human Services (HHS). ACTION: Notice of five AHRQ subcommittee meetings. SUMMARY: The subcommittees listed below are part of AHRQ's Health Services Research Initial Review Group
(IRG)Committee. Grant applications are to be reviewed and discussed at these meetings. Each subcommittee meeting will be closed to the public. DATES: See below for dates of meetings: 1. *Healthcare Safety and Quality Improvement Research (HSQR)* . *Date:* February 5-6, 2025. 2. *Healthcare Effectiveness and Outcomes Research (HEOR)* . *Date:* February 5-6, 2025. 3. *Health System and Value Research (HSVR)* . *Date:* February 13-14, 2025. 4. *Healthcare Research Training (HCRT)* . *Date:* February 27-28, 2025. 5. *Healthcare Information Technology Research (HITR)* . *Date:* February 27-28, 2025. ADDRESSES: Agency for Healthcare Research and Quality (Virtual Review), 5600 Fishers Lane, Rockville, Maryland 20857. FOR FURTHER INFORMATION CONTACT: (to obtain a roster of members, agenda or minutes of the non-confidential portions of the meetings.)Jenny Griffith, Committee Management Officer, Division of Policy, Coordination and Analysis, Office of Extramural Research Education and Priority Populations, Agency for Healthcare Research and Quality (AHRQ), 5600 Fishers Lane, Rockville, Maryland 20857, telephone
(301)427-1557. SUPPLEMENTARY INFORMATION: In accordance with the Federal Advisory Committee Act, 5 U.S.C. 1009(a)(2), AHRQ announces meetings of the above-listed scientific peer review groups, which are subcommittees of AHRQ's Health Services Research Initial Review Group Committee. The subcommittee meetings will be closed to the public in accordance with the provisions set forth in 5 U.S.C. 1009(d), 5 U.S.C. 552b(c)(4), and 5 U.S.C. 552b(c)(6). The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Agenda items for these meetings are subject to change as priorities dictate. Dated: December 12, 2024. Marquita Cullom, Associate Director. [FR Doc. 2024-29969 Filed 12-17-24; 8:45 am]
Connectionstraces to 2
Traces to 2 documents
Citation graph
cites case law
Cites 2Cited by 0 across 0 sources